Narrow search
Showing 1 - 10 of 175
Cover Image
Does waiting times decrease or increase operational costs in short and long-term? : evidence from Portuguese public hospitals
Madeira, André; Moutinho, Victor Ferreira; Fuinhas, … - In: The European journal of health economics 22 (2021) 8, pp. 1195-1216
Persistent link: https://www.econbiz.de/10012665561
Cover Image
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
Schain, Frida; Batyrbekova, Nurgul; Liwing, Johan; … - In: The European journal of health economics 22 (2021) 1, pp. 169-180
Persistent link: https://www.econbiz.de/10012434021
Cover Image
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? : a comparison across nine European countries in the European healthcare and social cost d...
Špacírová, Zuzana; Epstein, David; Espin, Jaime - In: The European journal of health economics 23 (2022) 9, pp. 1563-1575
Persistent link: https://www.econbiz.de/10013463124
Cover Image
Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity : a systematic review of economic evaluations
Jordan, Karen; Fawsitt, Christopher G.; Carty, Paul G.; … - In: The European journal of health economics 24 (2023) 4, pp. 575-590
Persistent link: https://www.econbiz.de/10014328039
Cover Image
Quality of life and healthcare costs of patients with allergic respiratory diseases : a cross-sectional study
Hillerich, Vivienne; Valbert, Frederik; Neusser, Silke; … - In: The European journal of health economics 25 (2024) 4, pp. 579-600
Persistent link: https://www.econbiz.de/10014564302
Cover Image
Mapping of head and neck cancer patient concerns inventory scores on to Euroqol-Five Dimensions-Five Levels (EQ-5D-5L) health utility scores
Thankappan, Krishnakumar; Patel, Tejal; Ajithkumar, … - In: The European journal of health economics 23 (2022) 2, pp. 225-235
Persistent link: https://www.econbiz.de/10013173598
Cover Image
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 ex...
Barbier, Michaela Carla; Pardo, Esther; Panje, Cédric … - In: The European journal of health economics 22 (2021) 5, pp. 669-677
Persistent link: https://www.econbiz.de/10012586580
Cover Image
Economics of mental well-being : a prospective study estimating associated health care costs and sickness benefit transfers in Denmark
Santini, Ziggi Ivan; Becher, Hannah; Jørgensen, Maja … - In: The European journal of health economics 22 (2021) 7, pp. 1053-1065
Persistent link: https://www.econbiz.de/10012615271
Cover Image
Is it too expensive to fight cancer? : analysis of incremental costs and benefits of the Croatian National Plan Against Cancer
Vrdoljak, Eduard; Sekerija, Mario; Plestina, Stjepko; … - In: The European journal of health economics 22 (2021) 3, pp. 393-403
Persistent link: https://www.econbiz.de/10012488623
Cover Image
Does the inclusion of societal costs change the economic evaluations recommendations? : a systematic review for multiple sclerosis disease
Rodríguez-Sánchez, Beatriz; Daugbjerg, S.; … - In: The European journal of health economics 24 (2023) 2, pp. 247-277
Persistent link: https://www.econbiz.de/10014327973